Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer TreatmentAasa Shimizu(University of Chicago), Tadashi Kimura(Osaka University)CancersApril 12, 202410.3390/cancers16081482Cited by 17SaveCiteExport RISWatch citationsRelated PapersExosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells|BMC Cancer|2018|148Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer|BMC Cancer|2022|7Patient-Derived Xenograft Mouse Model of a Rare Gynecologic Malignancy: Personalized Medicine for the Treatment of Mesonephric-Like Adenocarcinoma|Cureus|2025|0